Update on Hemorrhagic Occlusive Retinal Vasculitis

In this video from ASRS 2016, Dr. Andre Witkin discusses the latest on hemorrhagic occlusive retinal vasculitis (HORV), a rare and devastating complication linked to use of intraocular vancomycin during cataract surgery. Since the publication of his initial series of 6 patients (11 eyes) in the July 2015 issue of Ophthalmology, the ASRS and the American Society of Cataract and Refractive Surgeons (ASCRS) created a HORV taskforce to further define this condition. Dr. Witkin presents the latest data on this condition, including key clinical features, differential diagnosis, secondary complications and management. Dr. Witkin recommends aggressive treatment with steroids, anti-VEGF therapy and possibly laser surgery. Physicians should continue to report possible cases of HORV through the ASRS or ASCRS websites.